BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30439567)

  • 1. Thymineless Death by the Fluoropyrimidine Polymer F10 Involves Replication Fork Collapse and Is Enhanced by Chk1 Inhibition.
    Mani C; Pai S; Papke CM; Palle K; Gmeiner WH
    Neoplasia; 2018 Dec; 20(12):1236-1245. PubMed ID: 30439567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human Neuroblastoma.
    Lowery CD; VanWye AB; Dowless M; Blosser W; Falcon BL; Stewart J; Stephens J; Beckmann RP; Bence Lin A; Stancato LF
    Clin Cancer Res; 2017 Aug; 23(15):4354-4363. PubMed ID: 28270495
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined inhibition of Wee1 and Chk1 gives synergistic DNA damage in S-phase due to distinct regulation of CDK activity and CDC45 loading.
    Hauge S; Naucke C; Hasvold G; Joel M; Rødland GE; Juzenas P; Stokke T; Syljuåsen RG
    Oncotarget; 2017 Feb; 8(7):10966-10979. PubMed ID: 28030798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
    Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
    Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple DNA damage-dependent and DNA damage-independent stress responses define the outcome of ATR/Chk1 targeting in medulloblastoma cells.
    Krüger K; Geist K; Stuhldreier F; Schumacher L; Blümel L; Remke M; Wesselborg S; Stork B; Klöcker N; Bormann S; Roos WP; Honnen S; Fritz G
    Cancer Lett; 2018 Aug; 430():34-46. PubMed ID: 29753759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive RPA2 hyperphosphorylation promotes apoptosis in response to DNA replication stress in CHK1 inhibited cells.
    Zuazua-Villar P; Ganesh A; Phear G; Gagou ME; Meuth M
    Nucleic Acids Res; 2015 Nov; 43(20):9776-87. PubMed ID: 26271993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinately Targeting Cell-Cycle Checkpoint Functions in Integrated Models of Pancreatic Cancer.
    Chung S; Vail P; Witkiewicz AK; Knudsen ES
    Clin Cancer Res; 2019 Apr; 25(7):2290-2304. PubMed ID: 30538111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATR-Chk1 signaling pathway and homologous recombinational repair protect cells from 5-fluorouracil cytotoxicity.
    Fujinaka Y; Matsuoka K; Iimori M; Tuul M; Sakasai R; Yoshinaga K; Saeki H; Morita M; Kakeji Y; Gillespie DA; Yamamoto K; Takata M; Kitao H; Maehara Y
    DNA Repair (Amst); 2012 Mar; 11(3):247-58. PubMed ID: 22188649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the DNA replication checkpoint by pharmacologic inhibition of Chk1 kinase: a strategy to sensitize APC mutant colon cancer cells to 5-fluorouracil chemotherapy.
    Martino-Echarri E; Henderson BR; Brocardo MG
    Oncotarget; 2014 Oct; 5(20):9889-900. PubMed ID: 25301724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase.
    Wayne J; Brooks T; Massey AJ
    Oncotarget; 2016 Dec; 7(51):85033-85048. PubMed ID: 27829224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Checkpoint kinase‑1 inhibition and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repair.
    Fan Z; Luo H; Zhou J; Wang F; Zhang W; Wang J; Li S; Lai Q; Xu Y; Wang G; Liang A; Xu J
    Oncol Rep; 2020 Nov; 44(5):2152-2164. PubMed ID: 32901871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of tumour cell metabolism modulates sensitivity to Chk1 inhibitor-induced DNA damage.
    Massey AJ
    Sci Rep; 2017 Jan; 7():40778. PubMed ID: 28106079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Targeting of G9a and Checkpoint Kinase 1 Synergistically Inhibits Pancreatic Cancer Cell Growth by Replication Fork Collapse.
    Urrutia G; Salmonson A; Toro-Zapata J; de Assuncao TM; Mathison A; Dusetti N; Iovanna J; Urrutia R; Lomberk G
    Mol Cancer Res; 2020 Mar; 18(3):448-462. PubMed ID: 31822519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms.
    King C; Diaz HB; McNeely S; Barnard D; Dempsey J; Blosser W; Beckmann R; Barda D; Marshall MS
    Mol Cancer Ther; 2015 Sep; 14(9):2004-13. PubMed ID: 26141948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition.
    Gill MR; Harun SN; Halder S; Boghozian RA; Ramadan K; Ahmad H; Vallis KA
    Sci Rep; 2016 Aug; 6():31973. PubMed ID: 27558808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells.
    Parsels LA; Morgan MA; Tanska DM; Parsels JD; Palmer BD; Booth RJ; Denny WA; Canman CE; Kraker AJ; Lawrence TS; Maybaum J
    Mol Cancer Ther; 2009 Jan; 8(1):45-54. PubMed ID: 19139112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP Activity Fine-tunes the DNA Replication Choreography of Chk1-depleted Cells.
    Calzetta NL; González Besteiro MA; Gottifredi V
    J Mol Biol; 2021 May; 433(10):166949. PubMed ID: 33744317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHK1 activity is required for continuous replication fork elongation but not stabilization of post-replicative gaps after UV irradiation.
    Elvers I; Hagenkort A; Johansson F; Djureinovic T; Lagerqvist A; Schultz N; Stoimenov I; Erixon K; Helleday T
    Nucleic Acids Res; 2012 Sep; 40(17):8440-8. PubMed ID: 22753029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics.
    Chen Z; Xiao Z; Gu WZ; Xue J; Bui MH; Kovar P; Li G; Wang G; Tao ZF; Tong Y; Lin NH; Sham HL; Wang JY; Sowin TJ; Rosenberg SH; Zhang H
    Int J Cancer; 2006 Dec; 119(12):2784-94. PubMed ID: 17019715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Checkpoint Kinase 1 (CHK1) Inhibition Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Proton Irradiation via Rad51 Downregulation.
    Choi C; Cho WK; Park S; Shin SW; Park W; Kim H; Choi DH
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.